Gujarat Themis Biosyn Limited (BOM:506879)
India
· Delayed Price · Currency is INR 325.90
-8.05 (-2.41%)
At close: May 20, 2025
Gujarat Themis Biosyn Revenue
Gujarat Themis Biosyn had revenue of 395.20M INR in the quarter ending December 31, 2024, with 1.70% growth. This brings the company's revenue in the last twelve months to 1.55B, down -0.77% year-over-year. In the fiscal year ending March 31, 2024, Gujarat Themis Biosyn had annual revenue of 1.70B with 14.45% growth.
Revenue (ttm)
1.55B
Revenue Growth
-0.77%
P/S Ratio
22.19
Revenue / Employee
9.64M
Employees
159
Market Cap
34.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 1.70B | 214.37M | 14.45% |
| Mar 31, 2023 | 1.48B | 335.31M | 29.19% |
| Mar 31, 2022 | 1.15B | 242.91M | 26.82% |
| Mar 31, 2021 | 905.63M | 54.38M | 6.39% |
| Mar 31, 2020 | 851.24M | 440.75M | 107.37% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,155.91B |
| Infosys | 1,647.16B |
| Bajaj Finance | 369.88B |
Gujarat Themis Biosyn News
- 16 days ago - Gujarat Themis Biosyn starts commercial production at new API plant in Vapi, Gujarat - Business Upturn
- 6 months ago - Themis Medicare shares surge nearly 2% following amalgamation announcement - Business Upturn